Tallac Therapeutics

0 followers


Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a poten... Read more

Employees

11-50

Links

Org chart

Bora Han
Vice President, Preclinical Development
Curtis Hecht
Chief Business Officer
Mark Karbarz
Executive Director of Biologics Development, Head of CMC
Pavel Strop
Vice President, Head of Research
Kimberli Brill
Vice President, Clinical Sciences